Related Experiment Video
Updated: Jun 19, 2026
07:42
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease.
Tomas Ml Eagan1, Pål Aukrust, Per S Bakke
1Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway. tomas.eagan@med.uib.no
Respiratory Medicine
|October 20, 2009
Summary
Mannose-binding lectin (MBL) deficiency, linked to infections, was not more common in COPD patients or associated with disease severity. This study found no significant link between MBL deficiency and COPD or its progression.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Mannose-binding lectin (MBL) deficiency is implicated in increased susceptibility to infections and autoimmune conditions.
- Understanding the prevalence of MBL deficiency in Chronic Obstructive Pulmonary Disease (COPD) is crucial for assessing its potential role in disease pathogenesis and severity.
Purpose of the Study:
- To investigate the association between MBL deficiency and the presence of COPD.
- To determine if MBL deficiency correlates with the severity of COPD.
Main Methods:
- A case-control study involving 415 COPD patients and 231 healthy subjects aged 40-75.
- Plasma MBL levels were quantified using ELISA, with deficiency defined as <100ng/mL and low levels as <500ng/mL.
- Logistic regression models analyzed factors associated with MBL deficiency and its correlation with COPD severity indicators (FEV1, exacerbations, hypoxia, symptoms, treatments).
Main Results:
- Prevalence of MBL levels <100ng/mL was 22.2% in COPD patients versus 18.2% in healthy subjects (p=0.23).
- Prevalence of MBL levels <500ng/mL was 49.6% in COPD patients versus 42.9% in healthy subjects (p=0.10).
- Adjusted analyses showed no significant difference in MBL deficiency between COPD patients and controls, nor any association between MBL deficiency and COPD severity metrics.
Conclusions:
- MBL deficiency is not more prevalent in COPD patients compared to healthy individuals.
- No significant association was found between MBL deficiency and COPD severity, suggesting MBL deficiency does not play a major role in COPD pathogenesis or progression.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...